Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
Milestone Scientific (NYSE:MLSS), a developer of computerized drug delivery instruments for painless and precise injections, has scheduled a conference call for Friday, November 15th, 2024, at 8:30 AM Eastern Time. The call will discuss the company's third quarter 2024 financial results for the period ended September 30, 2024, along with corporate progress and developments. Investors can access the call via telephone or webcast, with an audio replay available through November 29th, 2024.
Milestone Scientific (NYSE:MLSS), un sviluppatore di strumenti informatici per la somministrazione di farmaci che offrono iniezioni indolori e precise, ha programmato una conference call per venerdì 15 novembre 2024, alle 8:30 AM ora orientale. La chiamata discuterà i risultati finanziari del terzo trimestre 2024 per il periodo conclusosi il 30 settembre 2024, insieme ai progressi e agli sviluppi aziendali. Gli investitori possono accedere alla chiamata tramite telefono o webcast, con una registrazione audio disponibile fino al 29 novembre 2024.
Milestone Scientific (NYSE:MLSS), un desarrollador de instrumentos informáticos para la entrega de medicamentos que permiten inyecciones indoloras y precisas, ha programado una conferencia telefónica para el viernes 15 de noviembre de 2024, a las 8:30 AM hora del Este. La llamada discutirá los resultados financieros del tercer trimestre de 2024 para el período terminado el 30 de septiembre de 2024, así como el progreso y los desarrollos de la empresa. Los inversores pueden acceder a la llamada a través de teléfono o webcast, con una reproducción de audio disponible hasta el 29 de noviembre de 2024.
Milestone Scientific (NYSE:MLSS)는 통증 없고 정확한 주사를 위한 컴퓨터 기반 약물 전달 기기를 개발하는 회사로, 2024년 11월 15일 금요일 동부 표준시 기준 오전 8시 30분에 컨퍼런스 콜을 진행할 예정입니다. 이 콜에서는 2024년 9월 30일 종료된 기간에 대한 2024년 3분기 재무 결과와 회사의 진행 상황 및 개발 사항에 대해 논의합니다. 투자자들은 전화 또는 웹 캐스트를 통해 콜에 접속할 수 있으며, 오디오 재생은 2024년 11월 29일까지 제공됩니다.
Milestone Scientific (NYSE:MLSS), un développeur d'instruments informatisés pour l'administration de médicaments destinés à des injections sans douleur et précises, a prévu une conférence téléphonique pour le vendredi 15 novembre 2024, à 8h30, heure de l'Est. L'appel discutera des résultats financiers du troisième trimestre 2024 pour la période se terminant le 30 septembre 2024, ainsi que des progrès et développements de l'entreprise. Les investisseurs peuvent accéder à l'appel par téléphone ou par webcast, avec une rediffusion audio disponible jusqu'au 29 novembre 2024.
Milestone Scientific (NYSE:MLSS), ein Entwickler von computergestützten Medikamentenabgabegeräten für schmerzfreie und präzise Injektionen, hat eine Telefonkonferenz für Freitag, den 15. November 2024, um 8:30 Uhr Eastern Time angesetzt. In der Konferenz werden die finanziellen Ergebnisse des dritten Quartals 2024 für den Zeitraum bis zum 30. September 2024 sowie der Unternehmensfortschritt und Entwicklungen besprochen. Investoren können über Telefon oder Webcast auf die Konferenz zugreifen, mit einer Audioaufzeichnung, die bis zum 29. November 2024 verfügbar ist.
- None.
- None.
ROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 15th, 2024, to discuss the company’s financial results for the third quarter ended September 30, 2024, as well as the company’s corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 169295. A webcast and replay of the call may be accessed at Webcast URL: https://www.webcaster4.com/Webcast/Page/2306/51651.
An audio replay of the call will be available through Friday, November 29th, 2024, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and by entering the access code: 51651.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS), a technology-focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.
Contact:
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020
FAQ
When is Milestone Scientific (MLSS) releasing Q3 2024 earnings?
How can investors access Milestone Scientific's (MLSS) Q3 2024 earnings call?
Until when will Milestone Scientific's (MLSS) Q3 2024 earnings call replay be available?
